Japan METI FY2026 Budget Doubles State Equity Investment in Next-Generation Semiconductor Mass Production (Rapidus)

Mechanism

Rapidus was designated on 21 November 2025 as Japan's official next-generation semiconductor manufacturer under the Act on Facilitation of Information Processing (2025-11-21-japan-meti-rapidus-information-processing-act-designation), making it eligible for a multi-year METI funding envelope reported at roughly JPY 1tn, with an initial JPY 100bn IPA equity tranche planned for FY2025. The 26 December 2025 Cabinet-approved FY2026 budget is the next annual appropriation against that envelope: it raises the IPA equity-investment line for next-generation semiconductor mass production from JPY 100bn (FY2025) to JPY 150bn (FY2026), lifting cumulative state equity in Rapidus to roughly JPY 250bn. IPA in turn holds the equity stake directly in Rapidus, alongside private capital from the 32-company consortium (Toyota, Sony, NTT, SoftBank, NEC, Denso and others) that has separately committed JPY 167.6bn.

The equity line sits within METI's broader FY2026 AI/semiconductor budget of JPY 1.239 trillion (up roughly 4x year-on-year), itself part of the "AI/Semiconductor Industry Base Strengthening Frame" launched in the November 2024 economic package, which commits the government to over JPY 10 trillion in public support for AI and semiconductors through FY2030 to catalyse over JPY 50 trillion in combined public-private investment over ten years. Japan's budget follows the ordinary cycle: Cabinet approval of the government's budget bill (26 December 2025) precedes formal Diet passage, expected in early 2026, with the fiscal year -- and the appropriation -- taking effect 1 April 2026.

Global Trade Alert classifies this specific budget line as an "Equity stake" intervention (MAST Chapter L, inward flow, national level) separate from the sister FY2026 METI budget line for the Housing and Buildings Integrated Energy-Conservation Investment Promotion Project (2025-12-26-japan-meti-fy2026-housing-building-energy-conservation-grant), which was approved in the same Cabinet decision.

Why severity 4

• Large, disclosed, escalating quantum. JPY 150bn for FY2026 alone

(up 50% from JPY 100bn in FY2025), taking cumulative state equity in a single strategic-technology company to ~JPY 250bn -- a real, quantified figure directly reported by METI and corroborated by multiple financial press outlets, hence severity_basis: quant.

• Targets Japan's flagship national semiconductor project. Rapidus is

the centerpiece of Japan's bid to re-enter leading-edge (2nm and beyond) logic manufacturing after exiting the leading edge in the 1990s-2000s; continued and growing state equity is a direct signal of national commitment ahead of the targeted April 2027 2nm mass-production start.

• **Consistent with the severity-4 rating already applied to the underlying

Rapidus designation** (2025-11-21-japan-meti-rapidus-information-processing-act-designation); this action is the next funded instalment against that same programme, not a new instrument, so it does not warrant a higher rating on its own.

Downstream implications

• Reinforces Rapidus's balance sheet ahead of its targeted April 2027 2nm

GAA mass-production start at the Chitose IIM-1 fab, reducing near-term financing risk for the project and for the domestic supply chain of equipment and materials vendors feeding it.

• Signals that Japan's semiconductor industrial-policy stack is on a rising

budget trajectory (4x AI/semiconductor budget growth year-on-year) rather than plateauing after the initial 2024-2025 framework announcements -- relevant to competing/complementary allied efforts (US CHIPS Act, EU Chips Act, Korea K-Chips Act) and to equipment suppliers (Tokyo Electron, Applied Materials, ASML) with exposure to the Rapidus buildout.

• Widens the gap in cumulative state support between Rapidus and other

national champions, a data point for assessing relative subsidy-race exposure across the trilateral chip-equipment perimeter (trilateral-chip-equipment-perimeter theme).

Open questions

• Confirmed Diet passage date and any amendments made to the equity-line

figure during ordinary Diet budget deliberations in early 2026 (the 26 December 2025 figure is the Cabinet's government-bill request, not necessarily the final enacted appropriation).

• Whether IPA structures the FY2026 tranche as further common equity,

preferred equity, or a hybrid instrument, and what governance rights (if any) attach.

• Confirmed cumulative private-sector capital raised alongside the FY2026

state tranche, updating the JPY 167.6bn (32-company) FY2025 baseline.